CBL Biopharma LLC

With nearly 30 years in the industry, CBL is a recognized leader in peptide technology and manufacturing, focused on cGMP manufacturing of Fmoc amino acids, solid phase resins, peptide intermediates, APIs and peptide generics. Committed to the highest quality and regulatory standards, the company applies GMP practices to peptide starting material manufacturing and offers production of peptide clinical and commercial material at all stages of drug development, with facilities designed for easy scale-up from small to commercial volumes.